SCHEMBL5400004

SCHEMBL5400004

CCOc1c(Cl)cccc1NC(=O)Nc1nc(CN(C)C(C)C)cs1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.44
▸ LMNA P02545 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ RAB9A P51151 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ PDE5A O76074 1/20 0.41
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ ROCK1 Q13464 1/20 0.40
▸ SHMT2 P34897 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5354933 0.91 L3MBTL1 (0.47) MAPTLMNASMN1; SMN2L3MBTL1TP53
SCHEMBL5252743 0.78 PDE5A (0.42) MAPTLMNASMN1; SMN2L3MBTL1TP53
SCHEMBL5221451 0.77 XIAP (0.39) MAPTLMNASMN1; SMN2L3MBTL1TP53
SCHEMBL5215989 0.77 MAPT (0.63) MAPTLMNASMN1; SMN2L3MBTL1RAB9A
SCHEMBL5252659 0.76 ALDH1A1 (0.49) MAPTSMN1; SMN2L3MBTL1RAB9ANPC1
SCHEMBL5216421 0.76 LPAR1 (0.52) MAPTLMNASMN1; SMN2L3MBTL1KMT2A
SCHEMBL5220598 0.74 HSD17B10 (0.50) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL5217930 0.74 KCNJ6 (0.48) MAPTLMNASMN1; SMN2RAB9ANPC1
SCHEMBL5221118 0.73 LPAR1 (0.51) L3MBTL1KMT2AMEN1POLB
SCHEMBL5219334 0.73 MEN1 (0.48) MAPTLMNASMN1; SMN2TP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809380-A2 INHIBITORS OF HIV-1 CAPSID FORMATION: SUBSTITUTED ARYL AMINOMETHYL THIAZOLE UREAS AND ANALOGUES THEREOF Achillion Pharmaceuticals, Inc. (US) 2007-07-25 — — EP claimed
WO-2006053323-A2 INHIBITORS OF HIV-1 CAPSID FORMATION: SUBSTITUTED ARYL AMINOMETHYL THIAZOLE UREAS AND ANALOGUES THEREOF ACHILLION PHARMACEUTICALS, INC. (US) 2006-05-18 — — WO claimed
Send feedback